Enzaplatovir
Enzaplatovir (BTA-585) is an orally available fusion inhibitor with antiviral activity for the study of respiratory syncytial virus infections and coronavirus disease (COVID-19) infections.
Product Specifications
CAS Number
1323077-89-9
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
377.4
Molecular Formula
C20H19N5O3
Notes
Research use only, not for human use.
Receptor
RSV
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
191695-01 48 Tests
Exendin 4 (EXENDIN-4) BioAssayTM ELISA Kit (Human) discontinued
Sign In for Pricing
View Details